C07F 9 - Compounds containing elements of the 5th group of the periodic system

Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2006
12/14/2006	US20060281175 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/14/2006	US20060280784 amphiphilic substance or a hydrophobic substance is modified with a glycerol derivative, which is useful as a surface modifier for producing a drug carrier; liposome, a fat emulsion, an emulsion, a micell and a fine particle crystal
12/14/2006	US20060280719 An addition polymer from an unsaturated monomer containing a phosphonate group and a phosphinate group separated from eachother by an optionally fluorinated methylene group; treatment of hyperphosphotemia, chronic renal failure, hyperparathyroidism, uremic bone disease, or osteoporosis
12/14/2006	DE102005026339A1 Kupfer(I)perfluorcarboxylat-Komplexe und ihre Verwendung zur Erzeugung von Kupfer Copper (I) perfluorocarboxylate complexes and their use for the production of copper
12/14/2006	CA2610792A1 Synthesis of glycerolipid carbamates and dicarbamates and their use as antitumor compounds
12/13/2006	EP1731616A1 Process for producing phospholipid containing long chain polyunsaturated fatty acid as constituent thereof and utilization of the same
12/13/2006	EP1731578A1 Primer for cyanoacrylate adhesive
12/13/2006	EP1731500A1 5-aminolevulinic acid salt, process for producing the same and use thereof
12/13/2006	EP1729815A2 Pegylated ion channel modulating compounds
12/13/2006	EP1729814A2 Pegylated ion channel modulating compounds
12/13/2006	EP1427424A4 Lpa receptor agonists and antagonists and methods of use
12/13/2006	EP1091930B1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
12/13/2006	CN1878781A phosphinic acid derivatives, beta-secretase inhibitors for the treatment of alzheimer's disease
12/13/2006	CN1877898A Electrolytic solution and battery
12/13/2006	CN1876668A C2-symmetrical bis ruthenium Diphosphine Ligand only with surface chirality
12/13/2006	CN1876667A Synthesis method of C2-symmetrical bis ruthenium Diphosphine Ligand only with surface chirality
12/13/2006	CN1876666A C2-symmetrical chirality bis ruthenium ligand and its synthesis method
12/13/2006	CN1876663A Chemiluminescent reagent 4-methox-4-(3-phosphorylphenyl)spiro[1,2- dioxycyclohexane-3,2'- adamantane], disodium salt synthesis method
12/13/2006	CN1876662A Phytic acid production process
12/13/2006	CN1876661A Fatty diol biipidol biphosphate synthesis method
12/13/2006	CN1289539C Supported bis(phosphorus) ligands and their use in the catalysis
12/13/2006	CN1289535C Polymerizable compounds and uses thereof
12/13/2006	CN1289515C Catalyst for asymmetric (transfer) hydrogenation
12/13/2006	CN1289513C Bridged biphospholes and metallocenes prepared therefrom
12/13/2006	CN1289512C Preparation method of biothion
12/13/2006	CN1289466C Pharmaceutical compounds
12/13/2006	CN1289455C 2-(2,6-dichlorophenyl)-diarylimidazoles
12/13/2006	CN1289448C Clean reclaiming process for byproduct chloromethane of glyphosate acid
12/12/2006	US7148382 Bathochromic mono- and bis-acylphosphine oxides and sulfides and their use as photoinitiators
12/12/2006	US7148367 Organometallic compound, its synthesis method, and solution raw material and metal-containing thin film containing the same
12/12/2006	US7148361 Synthesis of phosphono-substituted porphyrin compounds for attachment to metal oxide surfaces
12/12/2006	US7148349 Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
12/12/2006	US7148228 Heat Shock Protein 90 (HSP90); inflammatory, autoimmune, neurological, cardiac fibrogenetic and proliferative disorders and infections, tumors, leukemias, neoplasms, cancers, carcinomas, stroke, ischemia, metabolic diseases, and malignant disease
12/12/2006	US7148176 (adamantyl)nP(alkyl)m(1a); (adamantyl)o(Alkyl)qP (alkylene')P(adamantyl)r(alkyl)s , wherein adamantyl bonded to phosphorus atom in position 1, or 2, useful for refining halogenoaromatics
12/12/2006	US7148174 Catalysts for olefin polymerization with transition metal compound
12/12/2006	CA2326716C Triazolopurine derivative, pharmaceutical composition containing the derivative, adenosine a3 receptor ligand, and remedy for asthma
12/12/2006	CA2243726C Cyclopentadienyl/phosphinimine catalyst with one and only one activatable ligand
12/12/2006	CA2180624C Diphenyl-1,2,3-thiadiazoles as anti-inflammatory agents
12/07/2006	WO2006130842A1 Clickphosphines for transition metal-catalyzed reactions
12/07/2006	WO2006130353A2 Light-emitting device containing bis-phosphineoxide compound
12/07/2006	WO2006129688A1 2-aminobutanol compound and pharmaceutical use thereof
12/07/2006	WO2006129056A2 Process and novel salt
12/07/2006	WO2006128639A2 Process for the preparation and isolation of phosphatides
12/07/2006	WO2006128563A1 Low-viscosity ionic liquids
12/07/2006	WO2006090289A3 Compounds for reducing aggregation of amyloid beta-peptide
12/07/2006	WO2006084892A3 Process for the preparation of a dicarboxylic acid
12/07/2006	WO2006036881A3 Resorcinol carbonate-based phosphate ester compounds as flame retardants
12/07/2006	US20060276669 Process for preparing sulfonated arylphosphines
12/07/2006	US20060276658 Chemoselective ligation
12/07/2006	US20060276643 Amine-substituted diphenyldiphosphines
12/07/2006	US20060276538 Metal carnitine chelates
12/07/2006	US20060276437 Process for producing optically active dihydropyridinephosphonic ester
12/07/2006	US20060276329 Performing an asymmetric Mannich reaction, hydrophosphorylation reaction, aza Diels-Alder reaction, allylation, Strecker reaction or aminoalkylation in the presence of 1,1'-binaphthyl-2,2'-diyl hydrogenphosphate compound or the 5,5',6,6',7,7',8,8'-octahydro- derivative to prepare chiral compounds
12/07/2006	US20060275636 Novel electrolyte based on organic zirconium phosphonate complex also having a phosphonate, carboxy, sulfonate, or sulfonimide group; improved performance in newer higher temperature hydrogen or methanol fuel cells ; Zirconium(2-benzimidazolyl-2-ethylphosphonate) or Zr(HO2CCF2CH2CH2CH2PO3)2 for example
12/07/2006	US20060275544 Synthesizing nanocrystal cores made from a semiconductor material and size-separating a select population of nanocrystals; the crystals exhibit photoluminescence having a quantum yield of greater than 30% and emit visible light over a narrow range tunable over the entire visible spectrum
12/07/2006	CA2610575A1 Process for the preparation and isolation of phosphatides
12/07/2006	CA2610095A1 Chiral diphosphonites as ligands in the ruthenium-catalysed enantioselective reduction of ketones ~-ketoesters and ketimines
12/06/2006	EP1728796A1 Bisphosphite and process for producing aldehyde compound with the bisphosphite
12/06/2006	EP1727822A1 Novel compounds for modulating cell proliferation
12/06/2006	EP1727620A1 C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin
12/06/2006	EP1351965B1 Phosphoric flame-retardant and flame-retarding thermoplastic molding compounds
12/06/2006	EP1270577B1 Furoisoquinoline derivatives, process for producing the same and use thereof
12/06/2006	EP1091738B1 BICYCLIC sPLA 2 INHIBITORS
12/06/2006	CN1875025A Sterically hindered chelate phosphinite-phosphite ligand, catalyst, comprising at least one nickel(0) complex stabilized by said ligand and method for production of nitriles
12/06/2006	CN1874996A Aminopropanol derivatives
12/06/2006	CN1874974A Diastereoselective method of preparing olefins by means of the Horner-Wadsworth-Emmons reaction using a particular phosphonate which improves diastereoselectivity at all temperatures including at ambi
12/06/2006	CN1874768A N3 alkylated benzimidazole derivatives as MEK inhibitors
12/06/2006	CN1288118C Clean reclaiming process for byproduct chloromethane of glyphosate acid
12/06/2006	CN1288074C Process for producing orthophosphorous acid from high boiling byproducts of dialkyl ester phosphite
12/06/2006	CN1287889C Solid-liquid reaction
12/05/2006	US7145042 Reacting a diunsaturated compound with CO and H2 in the presence of a hydroformylation catalyst containing a complex of a group 8 transition metal with a ligand containing two chelating pnicogen atoms (P, Sb or As) linked by a fused ring bridging group, e.g., xanthenylene or triptycenediyl.
12/05/2006	US7145034 Method for producing N-phosphonomethylglycine
12/05/2006	US7145025 Structural carotenoid analogs for the inhibition and amelioration of disease
12/05/2006	US7145004 Treating a perfluoroalkylphosphorane with an alkaline earth metal hydroxide, an organometallic compound, or an organic base, and optionally treating with an acid in a reaction medium; use as ionic liquids, surfactants or phase-transfer catalysts
12/05/2006	US7144999 Modulation of hypoxia-inducible factor 1 alpha expression
12/05/2006	US7144839 Polymerization catalysts
12/05/2006	CA2224522C Process for the removal of n-phosphonomethyglycine from waste streams
11/2006
11/30/2006	WO2006128055A2 Novel phosphorus-containing thyromimetics
11/30/2006	WO2006127893A2 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
11/30/2006	WO2006127664A1 Fluorinated organic silicon coating material
11/30/2006	WO2006126612A1 Metal hydride complex, method of hydrogenating ring-opening polymerization polymer of cycloolefin, and process for producing product of hydrogenation of ring-opening polymerization polymer of cycloolefin
11/30/2006	WO2006126428A1 Optically active 3-methylcyclopentadecanone and method for producing intermediate thereof
11/30/2006	WO2006125769A1 Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
11/30/2006	WO2006125295A1 Derivatives of 4-or 5-aminosalicylic acid
11/30/2006	WO2006125293A1 Derivatives of 4- or 5-aminosalicylic acid
11/30/2006	WO2006080986A3 Coumarin-based cyanine dyes for non-specific protein binding
11/30/2006	US20060270862 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
11/30/2006	US20060270635 Derivatives of 4- or 5-aminosalicylic acid
11/30/2006	US20060270633 Crystalline form of fosinopril calcium
11/30/2006	US20060270629 5-bicyclo[3.1.0]hexanyl]pyrimidine-2,4-dione derivatives useful in the treatment or prevention of epilepsy, Parkinson's disease, Huntington's disease, respiratory system disorders, cancer and arrhythmias
11/30/2006	US20060269958 UV excitable energy transfer reagents
11/30/2006	US20060269931 labeling reagents for proteins and nucleic acids; for staining genetic probes; amplification; hybridization; substituted by electrophilic groups or nucleophilic groups; conjugate linked to a target molecule; detection of nucleic acids in the diagnosis
11/30/2006	US20060269779 Organic polymer light-emitting element material having gold complex structure and organic polymer light-emitting element
11/30/2006	US20060269587 Antisense restenosis composition and method
11/30/2006	DE102005023437A1 Verbindungen für organische elektronische Vorrichtungen Compounds for organic electronic devices
11/30/2006	CA2610647A1 Novel inhibitors of pyruvate kinase as therapeutic agents for cancer
11/30/2006	CA2609506A1 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
11/30/2006	CA2609224A1 Derivatives of 4-or 5-aminosalicylic acid
11/30/2006	CA2606675A1 Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
11/30/2006	CA2606498A1 Novel phosphinic acid-containing thyromimetics

1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 554